How Nanomedicine Could Revolutionize Cancer Drug Delivery
Discover how Oncotelic Therapeutics' Deciparticle platform and nanomedicine are transforming cancer treatment by improving drug delivery, potentially unlocking new value from existing therapies.
This news matters because it highlights a paradigm shift in oncology: instead of always seeking new drugs, improving delivery of existing treatments can enhance efficacy, reduce side effects, and lower costs. For patients, this could mean better outcomes and more accessible therapies, while investors may find opportunities in companies like Oncotelic that are pioneering drug-delivery innovations.
